Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Piotr Rutkowski MD, PhD

Prof. Piotr Rutkowski MD, PhD

Professor of Surgical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Piotr Rutkowski is Professor of Surgical Oncology at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland.

Dr. Rutkowski is the current Head of the Department of Soft Tissue/Bone Sarcoma and Melanoma, the Plenipotentiary of Head Director of Institute for National Oncological Strategy and Clinical Trials at the Maria Sklodowska-Curie National Research Institute of Oncology. He has participated in several investigator-driven trials in melanoma and sarcoma. He is a reviewer for several international scientific journals, as well as a member of the Editorial Board of Annals of Surgical Oncology and European Journal of Surgical Oncology.

Dr. Rutkowski is an active member of the EORTC Melanoma Group; EORTC Soft Tissue and Bone Sarcoma Group, where he chaired the Local Treatment Subcommittee and the Membership Committee of the EORTC Board. He is a member of several Polish and international scientific societies (President of Polish Oncological Society, Board member of Polish Society Surgical Oncology, Ex-member of the Board of Directors of the Connective Tissue Oncology Society, member of International Affair Committee of ASCO, Global Curriculum Committee of ESMO). Prof. Rutkowski has authored or co-authored over 500 scientific papers in Polish and international journals (with an impact factor of above 4000, index-H:80, citation index >30000, rewarded Highly Cited Researcher in Clinical Medicine 2021 and 2022), and is co-author of national and international recommendations for sarcoma and melanoma. He is working very closely with national patient advocacy groups for GIST/sarcoma and melanoma, coordinating Polish Sarcoma Group and is Chairman of the Melanoma Academy in Poland. Member of Council of Agency of Medical Research. Chair of Task Group of Ministry of Health, Poland for National Oncological Strategy.

Recent Contributions to PracticeUpdate:

  1. Pembrolizumab for Rare and Ultra-Rare Sarcomas